Neural Responsiveness to Reward as an Index of Depressive Symptom Change Following Cognitive-Behavioral Therapy and SSRI Treatment.

CONCLUSIONS: These findings highlight neural responsiveness to reward as both a mechanism and a predictor of depressive symptom change that may be used serve as an objective index of symptom improvement. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT01903447. PMID: 29894598 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29894598?dopt=Abstract

Source: Journal of Clinical Psychiatry - June 14, 2018 Category: Psychiatry Tags: J Clin Psychiatry Source Type: research